Experts agree new weight loss drugs are needed to treat an estimated 75 million obese adults in the U.S., but the FDA had thought some were not safe enough.
Regulators said they've approved new suppliers for two crucial cancer drugs, but there are currently 283 other separate drugs in short supply.
The new infant bottle comes with a plastic syringe that's to be inserted into a flow restrictor for the correct dosage, but the restrictor often falls into the bottle.
The FDA had previously rejected the pill for potential heart problems and birth defects in women who become pregnant while taking the drug.
The multibillion-dollar trade has largely been relegated to poor countries with lax regulations, but officials worry more counterfeits will be smuggled into America.
Johnson and Johnson is becoming notorious for a long string of recalls and poor production practices, which leaves me wondering: How have they managed to avoid any genuine outcry?
Doctors are panicking because methotexate is the key treatment for a common childhood cancer called acute lymphoblastic leukemia, and can cure 90 percent of cases.
Federal health officials say Accurate Set has been legally barred from making and selling a variety of dental products due to violations at its manufacturing facility.
Health industry workers worry India may bow to EU demands for strict IP protections, which would close down the supply of medicines to the world's poorest.
The recent decline of venture financing is threatening innovation in the $300 billion global market for medical devices.
Wisconsin-based MRPC, a single-source provider of medical device components and assemblies, has completed construction of a new cleanroom for the molding of medical components.
The British orthopedics maker was accused by the DOJ and SEC of bribing doctors employed by the Greek government for more than a decade to win business.
Buzzwords such as "blockbuster" and "cash cow" have all but disappeared, and have been replaced "headwinds," ''austerity" and "efficiency."
Tests showed that tablets produced in the facility contained massive doses of anti-malarial medicine that poisoned 100 heart patients.
CEO Ian Read said in a statement that patent losses, including that of Lipitor, cost the company $5 billion throughout 2011.
The government groups and charities alone are committing just over $785 million in new funding to protect more than a billion people.
A judge placed Jean-Claude Mas, the founder and former chief of Poly Implant Prothese, under investigation for "involuntary injury."
The suit alleges Pfizer allowed employees to amass such high concentrations of company stock that workers were extremely vulnerable to market fluctuations.
The world's largest maker of construction and mining equipment saw profit jump 60 percent, with a net income of $1.55 billion.
Jean-Claude Mas, who founded Poly Implant Prothese, was implicated in a cancer scandal affecting tens of thousands of women worldwide.
Medical device and drug maker Abbott Laboratories said it will lay off 700 employees as part of ongoing restructuring efforts.
The Parsippany, N.J., company said its generic versions of J&J and Pfizer medicines help its revenue jump 28 percent over 2010.
Pioneer Surgical Technology today announces the grand opening of its newly expanded Greenville manufacturing facility, which houses the primary manufacturing operations for products sold in the United States and Europe.
The drug, Gilenya, could trigger heart problems within 24 hours after patients take their first dose.